The quality of life assessment after radical prostatectomy with usage of MEB questionnaire 13.1

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


The quality of life assessment for 180 patients with prostate cancer after radical prostatectomy was carried out. For this purpose we used the original MEB questionnaire 13.1 which included 65 questions divided in to the several blocks: urination, erectile dysfunction, pane, general quality of life assessment and the others. The performed analysis showed to the internal inquirer’s questions coordination, the correspondence between the received during the questionnaire usage results and the results after standard questionnaire usage (PC-QoL, IPSS, IIEF, OAB-q) as well as statement simplicity for the patients.

Full Text

Restricted Access

About the authors

Salman Hasunovich Al-Shukri

First St.-Petersburg State I. P. Pavlov Medical University

Email: al-shukri@mail.ru
doctor of medical science, professor, head of the department. Department of Urology.

Yevgeniy Stanislavovich Nevirovich

First St.-Petersburg State I. P. Pavlov Medical University

candidate of medical science, head of Urological Unit

Adel Salmanovich Al-Shukri

First St.-Petersburg State I. P. Pavlov Medical University

doctor of medical science, professor, Urology Department

Anton Gennadyevich Boriskin

First St.-Petersburg State I. P. Pavlov Medical University

Email: flounder@yandex.ru
candidate of medical science, assistant professor, Urology Department

Yuliya Valeryevna Tyurina

First St.-Petersburg State I. P. Pavlov Medical University

student

References

  1. Hoffman R. M. Clinical Practice. Screening for Prostate Cancer // New Engl. J. Med. 2011. Vol. 365, N 21. P. 2013–2019.
  2. Lu-Yao G. L., Albertsen P. C., Moore D. F. et al. Outcomes of localized prostate cancer following conservative management // JAMA. 2009. Vol. 302, N 11. P. 1202–1209.
  3. Greene K. L., Albertsen P. C., Babaian R. J. et al. Prostate specific antigen best practice statement: 2009 update // J. Urol. 2009. Vol. 182, N 5. P. 2232–2241.
  4. Phillips C. Study questions benefit of surgery in some men with early-stage prostate cancer // NCI cancer bulletin. 2011. Vol. 8, N 11.
  5. Roobol M. J., Kerkhof M., Schroeder F. H. et al. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) //EurUrol. 2009. Vol. 56, N 4. P. 584–591.
  6. Thompson J. M.Jr., Goodman P. J., Tangen C. M. et al. Long-Term Survival of Participants in the Prostate Cancer Prevention Trial //New Engl. J. Med. 2013. Vol. 369, N 7. P. 603–610.
  7. Schroeder F. H., Hugosson J., Roobol M. J. et al. Prostate-Cancer Mortality at 11 Years of Follow-up // New Engl. J. Med. 2012. Vol. 366, N 11. P. 981–990.
  8. Bill-Axelson A., Holmberg L., Ruutu M. et al. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer // New Engl. J. Med. 2011. Vol. 364, N 18. P 1708–1717.

Statistics

Views

Abstract - 398

PDF (Russian) - 297

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2013 Al-Shukri S.H., Nevirovich Y.S., Al-Shukri A.S., Boriskin A.G., Tyurina Y.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies